Slide 1: Q1 2018 Results
Q1 2018 Results 8 May 2018 AGFA @
Slide 2: Profit & Loss: Key Figures (in million Euro)
Profit & Loss: Key Figures (in million Euro) Q1'17 Q1'18 Δ% (excl. curr. ) Sales 588 549 -6,7%(-1,3%) Gross Profit* 193 178 -7,5% as a % of sales 32,7% 32,4% SG&A* -129 -120 -6,3% as a % of sales 21,8% 21,9% R&D* -38 -37 -0,7% Other operating items* -1 4 Recurring EBITDA* 39 37 -3,5% as a % of sales
Slide 3: Profit & Loss: Key Figures (in million Euro)
Profit & Loss: Key Figures (in million Euro) Q1'17 Q1'18 % change Recurring EBIT 26 24 -5,3% Restructuring and non-recurring -3 -4 Operating result 23 20 -14,4% Non-operating result -12 -10 Share of result of equity accounted 0 0 investees - net of income tax Profit before taxes 11 10 Taxes and mino
Slide 4: Net Financial Debt (in million Euro)
Net Financial Debt (in million Euro) 191 176 175 126 94 102 83 58 52 40 31 Q1’17 27 22 18 19 -18 Q1'14Q2'14Q3'14Q4'14Q1'15Q2'15Q3'15Q4'15Q1'16Q2'16Q3'16Q4'16Q1'17Q2'17Q3'17Q4'17Q1'18 -37 4
Slide 5: Working Capital: Key Figures (in million Euro/days)
Working Capital: Key Figures (in million Euro/days) Q4 2017 Q4 2017 Q1 Old Restated* 2018 Definition Inventories (Mio Eur) 487 476 505 (29) • DSO in days 108 105 113 (8) Trade Receivables, Contract 389 393 366 27 Assets, Contract liabilities (Mio Eur) • DSO in days 55 55 59 (4) Trade Payables (Mio E
Slide 6: Main Group Drivers behind Key Figures
Main Group Drivers behind Key Figures Q1 2018 • The strength of the Euro versus other currencies had a strong impact on the Agfa-Gevaert Group’s top line. Excluding these currency effects, the revenue decline was limited to 1.3%. The Agfa HealthCare and Agfa Specialty Products business groups perfor
Slide 7: Graphics
Graphics AGFA @
Slide 8: Graphics: YTD Sales per Business Segment
Graphics: YTD Sales per Business Segment 1Q 2018 100% = 259 million Euro Inkjet, Software, Service 24% Analog Prepress 9% Digital Prepress 67% 8
Slide 9: Graphics: Key Figures (in million Euro)
Graphics: Key Figures (in million Euro) Q1'17 Q1'18 Δ% (excl. curr.) Sales 300 259 -13,7%(-7,4%) Gross Profit* 90 70 -22,0% as a % of sales 29,9% 27,0% SG&A* -66 -60 -7,8% as a % of sales 21,7% 23,2% R&D* -11 -11 0,0% Other operating items* 1 4 Recurring EBITDA* 19,9 8,2 -58,6% as a % of sales 6,6%
Slide 10: Graphics: Main Drivers behind Key Figures
Graphics: Main Drivers behind Key Figures Q1 2018 • Excluding the effects of the strength of the Euro and of the decision to discontinue certain prepress-related reseller activities in the United States, Agfa Graphics’ top line decreased by 5,4%. The prepress segment’s top line was impacted by the s
Slide 11: HealthCare
HealthCare AGFA @
Slide 12: HealthCare: YTD Sales per Business Segment
HealthCare: YTD Sales per Business Segment 1Q 2018 100% = 239 million Euro Hardcopy 23% Classic Radiology CR/Modalities 6% 20% Imaging IT* HIS/CIS 31% 20% HealthCare IT = 51% * Includes Radiology and Cardiology IT 12
Slide 13: HealthCare: Key Figures (in million Euro)
HealthCare: Key Figures (in million Euro) Q1'17 Q1'18 Δ% (excl. curr.) Sales 239 239 -0,1%(+4,7%) Gross Profit* 91 93 3,1% as a % of sales 37,9% 39,1% SG&A* -57 -55 -4,5% as a % of sales 23,8% 22,7% R&D* -24 -23 -1,0% Other operating items* 0 1 Recurring EBITDA* 16,3 23,2 42,1% as a % of sales 6,8%
Slide 14: HealthCare: Main Drivers behind Key Figures
HealthCare: Main Drivers behind Key Figures Q1 2018 • Excluding currency effects, Agfa HealthCare realized a 4.7% top line growth based on the strong performances of the growth engines and the improved hardcopy volumes in China. The business group’s Direct Radiography growth engine posted double-dig
Slide 15: Specialty Products
Specialty Products AGFA @
Slide 16: Specialty Products: Key Figures (in million Euro)
Specialty Products: Key Figures (in million Euro) Q1'17 Q1'18 Δ% (excl. curr. ) Sales 49 51 4,1%(6,8%) Gross Profit* 12 15 19,7% as a % of sales 24,9% 28,6% SG&A* -6 -6 0,0% as a % of sales 12,8% 11,6% R&D* -3 -2 -8,0% Other operating items* -1 -1 Recurring EBITDA* 3,5 6,7 93,0% as a % of sales 7,1%
Slide 17: Specialty Products: Main Drivers behind Key Figures
Specialty Products: Main Drivers behind Key Figures Q1 2018 • Agfa Specialty Products’ top line grew by 4.1% to 51 million Euro. Particularly strong sales figures were reported by the Printed Circuit Board business, Synaps Synthetic Paper and the Specialty Chemicals business (including Orgacon Elect
Slide 18: Questions & Answers
Questions & Answers AGFA @